BioCentury
ARTICLE | Clinical News

HVTN 100: Phase I/II started

February 23, 2015 8:00 AM UTC

NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and the HIV Vaccine Trials Network (HVTN) began the placebo-controlled, South African Phase I/II HVTN 100 trial to evaluate 8 injec...